A thousand words about the challenges of photodynamic therapy

by Jerzy Jankun
Published 2019-09-01

Richard Hart (1947-2018)

by Jerzy Jankun
Published 2019-06-01

COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs.

by Jerzy Jankun
Published 2020-04-01

Specific inhibitors of urokinase plasminogen activator for treatment of cancers; In silico approach

by Benjamin Talbot, Jerzy Jankun
Published 2020-05-01

Bifunctional inhibitors of urokinase and metalloproteinase-9 for cancer treatment - in silico evaluation

by Shawn P. Brewer, Jerzy Jankun
Published 2018-09-01

Application of Long-Acting VLHL PAI-1 during Sutureless Partial Nephrectomy in Mice Reduces Bleeding

by Khaled Shahrour, Rick Keck, Jerzy Jankun
Published 2015-01-01

Editorial: what editors welcome

by Jerzy Jankun, Roberta Redfern, Arjun Sabharwal
Published 2018-06-01

Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?

by Marzena Wyganowska-Świątkowska, Maja Matthews-Kozanecka, Teresa Matthews-Brzozowska, Ewa Skrzypczak-Jankun, Jerzy Jankun
Published 2018-01-01

Evaluation of 12-Lipoxygenase (12-LOX) and Plasminogen Activator Inhibitor 1 (PAI-1) as Prognostic Markers in Prostate Cancer

by Tomasz Gondek, Mariusz Szajewski, Jarosław Szefel, Ewa Aleksandrowicz-Wrona, Ewa Skrzypczak-Jankun, Jerzy Jankun, Wieslawa Lysiak-Szydlowska
Published 2014-01-01